Zobrazeno 1 - 10
of 115
pro vyhledávání: '"V, Feillel"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S. Lemery, Hervé Curé, V. Feillel, Ph. Chollet, Xavier Durando, Catherine Abrial, Marianne Leheurteur, Jacques Dauplat, G. Le Bouedec, Marie-Ange Mouret-Reynier
Publikováno v:
The Breast. 15:9-19
Summary The clinical benefits of endocrine therapy for patients with hormonosensitive breast cancer are well established. For many years, five years’ treatment with tamoxifen was the gold standard of adjuvant treatment. The recent development of ne
Publikováno v:
La Presse Médicale. 34:208-212
Resume Objectif Preciser le role du curage ganglionnaire axillaire dans les carcinomes canalaires in situ micro-invasifs (CCIS-MI) du sein a partir d’une serie de 107 cas consecutifs. Methodes Travail anatomoclinique retrospectif monocentrique avec
Publikováno v:
Gynécologie Obstétrique & Fertilité. 28:798-805
Resume Etude retrospective (1985–1998) portant sur les caracteristiques operatoires et anatomopathologiques de 155 cancers infracliniques du sein reveles par une opacite stellaire. Materiels et methodes – Les mammographies provenaient du depistag
Autor:
J.L. Misset, P. Chollet, I. van Praagh, Sabine Charrier, E. Brain, Hervé Curé, J. P. Ferriere, V. Feillel, Jacques Dauplat, M. De Latour
Publikováno v:
European Journal of Cancer. 33:862-866
Neoadjuvant chemotherapy is used to improve patients' survival in locally-advanced and inflammatory breast cancer and to increase conservative surgical procedures in bulky tumours. Pathological complete responses are unusual. The aim of this pilot st
Autor:
Chassagne J, J.-L. Achard, Y J Bignon, Hervé Curé, E. Belembaogo, Pierre Verrelle, Fabrice Kwiatkowski, V. Feillel, Ph. Chollet, G. Le Bouëdec
Publikováno v:
European Journal of Cancer. 28:896-900
126 patients with non-inflammatory operable breast cancer, who otherwise would have undergone modified radical mastectomy (MRM), were treated by induction chemotherapy. Before treatment, every patient had a local and general assessment, and pathologi
Publikováno v:
Presse medicale (Paris, France : 1983). 34(3)
Specify the role of axillary lymph node removal in micro-invasive in situ duct carcinomas (DCIS-MI) of the breast with a series of 107 consecutive cases.Single-centre, retrospective, anatomoclinical study with application of the European guidelines a
Autor:
Jean-Pierre Ferriere, Hervé Curé, Catherine Abrial, Guillaume Lebouedec, S. Amat, Philippe Chollet, V. Feillel, Frédérique Penault-Llorca, Marie-Ange Mouret-Reynier, Fabrice Kwiatkowski
Publikováno v:
Clinical breast cancer. 5(4)
This study investigated the efficacy and tolerability of FEC 100 (epirubicin 100 mg/m2 with 5-fluorouracil 500 mg/m2 and cyclophosphamide 500 mg/m2) every 21 days as neoadjuvant chemotherapy in women with stage I-III primary operable breast cancer. F
Autor:
Pierre-Jean Bargnoux, V. Feillel, Marie-Paule Vasson, Guy Beaujon, Régine Minet-Quinard, Bernard Beaufrère, Fabrice Kwiatkowski, Luc Cynober, Isabelle Van Praagh
Publikováno v:
Cancer investigation. 22(2)
Various alterations of aminoacidemia have been described during breast cancer. The aim of this study was first to establish the specific modifications of plasma-free amino acid concentrations by a comparative study of 19 patients with mammary tumors
Autor:
Guillaume Le Bouedec, Florence Mishellany, Philippe Chollet, V. Feillel, Monique De Latour, S. Amat, Anne Cayre, Jean-Pierre Ferriere, Frédérique Penault-Llorca
Publikováno v:
International journal of oncology. 22(6)
Induction chemotherapy provides an excellent model for evaluation of potential predictive factors. We studied expression of SBR grade, estrogen (ER) and progesterone (PR) receptors, HER2, Ki67 and P53 on core biopsies before and after chemotherapy in